Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference

09/02/2021 | 04:06pm EDT

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.

Guardant Health’s management is scheduled to participate in a fireside chat on Thursday, September 9 at 1:15 p.m. Pacific Time / 4:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com

Media Contact:
Anna Czene
press@guardanthealth.com


Primary Logo


ę GlobeNewswire 2021
All news about GUARDANT HEALTH, INC.
10/13INSIDER SELL : Guardant Health
MT
10/08GUARDANT HEALTH : to Report Third Quarter Financial Results on November 4, 2021
BU
10/05GUARDANT HEALTH : Commences Study to Evaluate Ability of Reveal Liquid Biopsy Test to Pred..
MT
10/05GUARDANT HEALTH : Initiates ORACLE Study to Evaluate Performance of Guardant Reveal™..
BU
10/05Guardant Health Initiates ORACLE Study to Evaluate Performance of Guardant RevealÖ Bloo..
CI
10/01Health Care Stocks Broadly Higher Late Friday
MT
10/01MARKET CHATTER : Guardant Health's Shares Sink on Reports of NeoGenomics Takeover Plans; S..
MT
10/01GUARDANT HEALTH : Reportedly Mulls Acquisition of Diagnostics Services Provider NeoGenomic..
MT
10/01GUARDANT HEALTH SAID TO WEIGH TAKEOV : Bloomberg
MT
09/15GUARDANT HEALTH : Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360« Liquid..
BU
More news
Analyst Recommendations on GUARDANT HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 368 M - -
Net income 2021 -379 M - -
Net cash 2021 101 M - -
P/E ratio 2021 -26,7x
Yield 2021 -
Capitalization 10 292 M 10 292 M -
EV / Sales 2021 27,7x
EV / Sales 2022 20,6x
Nbr of Employees 864
Free-Float 95,6%
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 101,60 $
Average target price 161,31 $
Spread / Average Target 58,8%
EPS Revisions
Managers and Directors
Helmy Eltoukhy Chairman & Co-Chief Executive Officer
AmirAli H. Talasaz President, Co-Chief Executive Officer & Director
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors